<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17035" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Abnormal Papanicolaou Smear</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mayer</surname>
            <given-names>Christopher</given-names>
          </name>
          <aff>Albany Medical College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahdy</surname>
            <given-names>Heba</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Mayer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Heba Mahdy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17035.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cervical cancer screening has become one of the cornerstones of&#x000a0;preventative screening in the gynecological world. George Papanicolaou invented this screening event, hence the name "Pap" smear, and was first used in 1943. The test collects cervical cells near the cervical transitional (transformation) zone and determines if any of them have precancerous changes. Since 1943, few classification systems have been put in place to detail the different types of collected cells; the current system followed in the United States is the 2014 Bethesda System for Reporting Cervical Cytology.<xref ref-type="bibr" rid="article-17035.r1">[1]</xref></p>
        <p>Guidelines for Pap smear testing frequency vary between the United States Preventative Service Task Force and the American College of Obstetricians and Gynecologists but are&#x000a0;recommended for women between 21 and 65. Screening is not recommended for those younger than 21. The prevalence of abnormal Pap smears is around 3.8%. At least 50 million Pap smears are performed yearly.<xref ref-type="bibr" rid="article-17035.r2">[2]</xref>&#x000a0;In 2019, there were an estimated 13,000 women diagnosed with cervical cancer and 4000 women who died from cervical cancer.<xref ref-type="bibr" rid="article-17035.r3">[3]</xref></p>
      </sec>
      <sec id="article-17035.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Pap smears are the screening tool to assess cellular changes within the cervix. Documentation exists for varying levels of sensitivity and specificity for the test.<xref ref-type="bibr" rid="article-17035.r4">[4]</xref>&#x000a0;Because the test is not&#x000a0;100% sensitive, it is important to conduct pap smears routinely.<xref ref-type="bibr" rid="article-17035.r5">[5]</xref><xref ref-type="bibr" rid="article-17035.r6">[6]</xref>&#x000a0;From a societal lens, there are racial disparities in&#x000a0;the timeliness of cervical cancer diagnosis. The localized diagnosis of cervical cancer is 47% in White and 36% in Black individuals. The regionalized diagnosis of cervical cancer is 35% in White and 41% in Black populations.<xref ref-type="bibr" rid="article-17035.r3">[3]</xref>&#x000a0;There is a decrease in the early detection of cervical cancer in Black women, which results in detection when the disease has further progressed.</p>
      </sec>
      <sec id="article-17035.s3" sec-type="Causes">
        <title>Causes</title>
        <p>The primary cause of abnormal pap smears is associated with infection by human papillomavirus (HPV). HPV serotypes 16/18 are the most common strains that cause cervical cancer.<xref ref-type="bibr" rid="article-17035.r7">[7]</xref>&#x000a0;Both of these serotypes appear in 70% of cervical cancer cases. Lower-risk HPV serotypes include serotypes 6 and 11. Smoking has also been shown to increase the risk of cervical cancer.<xref ref-type="bibr" rid="article-17035.r8">[8]</xref>&#x000a0;The carcinogens in the smoke disseminate throughout the body and are identifiable in cervical mucus. These carcinogens can alter the oncogene balance within these cells, resulting in cancerous growth. Research also shows that women who have a high number of full-term pregnancies are at an increased risk of developing cervical cancer.<xref ref-type="bibr" rid="article-17035.r9">[9]</xref>&#x000a0;Women who take oral contraception for prolonged periods have a temporary increase in the risk of acquiring cervical cancer.<xref ref-type="bibr" rid="article-17035.r10">[10]</xref>&#x000a0; Additionally, patients who have human immunodeficiency virus or are immunocompromised have an increased risk of acquiring HPV, which can lead to cervical cancer. Both of these reduce the ability of the immune system to clear the virus. From a more historical reference, children who had their mother take diethylstilbestrol during the pregnancy are at elevated risk of clear cell adenocarcinoma of the vagina and cervix.<xref ref-type="bibr" rid="article-17035.r11">[11]</xref>&#x000a0;DES was prescribed to pregnant mothers between 1938 and 1974 to help reduce the risks of&#x000a0;premature labor; it is no longer prescribed.</p>
      </sec>
      <sec id="article-17035.s4" sec-type="Anatomical Pathology">
        <title>Anatomical Pathology</title>
        <p>Cervical cancer screening requires acquiring cervical cells in the transitional zone in the cervix. The transitional zone is also called the squamocolumnar junction because it is the joining process of the ectocervix and the endocervix. The ectocervix is comprised of non-keratinized stratified squamous epithelium, while the endocervix is simple columnar epithelium. The simple columnar cells also have glandular cells that secrete mucus.</p>
        <p>The anatomic pathology for cervical cytology mainly arises from the 2 cell types found in the transitional zone: epithelial and glandular. Epithelial cell pathology is graded in an ascending fashion:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Atypical squamous cells of undetermined significance</bold>: This is the most common abnormal pap smear diagnosis.<xref ref-type="bibr" rid="article-17035.r12">[12]</xref>&#x000a0;This diagnosis usually correlates with an HPV infection. This diagnosis can reflect precancerous changes in the cells but can also be caused by inflammation or as a response to trauma (see <bold>Image.</bold> Squamous Cells, Acute Inflammation).</p>
          </list-item>
          <list-item>
            <p><bold>Atypical squamous cells- not excluding high-grade intraepithelial lesions</bold>: This diagnosis is exceedingly rare and requires colposcopy to assume that there truly are no high-grade intraepithelial lesions.</p>
          </list-item>
        </list>
        <p>If the pathologist can determine that there is a morphological change within the cells,&#x000a0;the following is the nomenclature used:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Low-grade squamous intraepithelial lesions:</bold> This definition covers the spectrum of changes in squamous cells that can potentially progress to squamous cell carcinoma. This finding is highly suggestive of an HPV infection. This nomenclature includes cervical intraepithelial neoplasia (CIN) 1 and mild dysplasia. While this finding is present in 2% of all pap smears, the regression rate of low-grade squamous intraepithelial lesions (LSIL) in 2 years is over 85%.<xref ref-type="bibr" rid="article-17035.r13">[13]</xref>&#x000a0;Less than a quarter of LSIL findings will progress to higher-grade lesions.</p>
          </list-item>
          <list-item>
            <p><bold>High-grade squamous intraepithelial lesions</bold>: This definition is a general title for abnormalities in squamous cells with a serious concern of progressing to cervical cancer. This finding is highly suggestive of an HPV infection. This title includes the historical terminology of CIN2, CIN3, moderate dysplasia, severe dysplasia, and carcinoma in situ.<xref ref-type="bibr" rid="article-17035.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Squamous cell carcinoma</bold>: This is rarely diagnosed on a pap smear.<xref ref-type="bibr" rid="article-17035.r15">[15]</xref>&#x000a0;This condition only occurs with a significant progression of cervical cancer.</p>
          </list-item>
        </list>
        <p>In addition to the epithelial cells, the pathologist can identify abnormal glandular cells, which&#x000a0;are graded in an ascending fashion:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Atypical glandular cells:</bold> This cell type can be found in the endocervix and can also appear in other parts of the reproductive tract, like the endometrium. It is diagnosed in 0.3% of all Pap smears. Atypical glandular cells (AGC) identify cells that have progressed beyond temporary inflammatory changes but have not mutated as much to be diagnosed as adenocarcinoma.<xref ref-type="bibr" rid="article-17035.r16">[16]</xref>&#x000a0;AGC divides into 2 main areas that are either "undetermined significance" or&#x000a0;"undetermined significance with a squamous abnormality." Squamous abnormalities can be found in 31% of AGC diagnoses and are more likely to appear in patients under the age of 35.<xref ref-type="bibr" rid="article-17035.r17">[17]</xref>&#x000a0;ACG is also divided based on the suspected origin of the glandular cells. A diagnosis of AGC&#x000a0;increases the risk of cancers throughout a woman's reproductive tract.
<list list-type="bullet"><list-item><p>Atypical glandular cells favor endocervical origin: This diagnosis is least likely to&#x000a0;have associated endometrial cancer.<xref ref-type="bibr" rid="article-17035.r18">[18]</xref></p></list-item><list-item><p>Atypical glandular cells favor endometrial origin: This diagnosis is most likely to have associated endometrial cancer.<xref ref-type="bibr" rid="article-17035.r18">[18]</xref></p></list-item><list-item><p>Atypical glandular cells not otherwise specified: This diagnosis is in the middle, having an association with endometrial cancer.<xref ref-type="bibr" rid="article-17035.r18">[18]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Endocervical adenocarcinoma in situ</bold>: This diagnosis has become more frequent over the previous decades. The prevalence is 11.2 per 100,000 and is most likely to be diagnosed in patients between the age of 30&#x000a0;to 40.<xref ref-type="bibr" rid="article-17035.r19">[19]</xref>&#x000a0;Endocervical adenocarcinoma in situ (AIS) usually correlates with a squamous lesion. Like the other abnormal Pap smear findings, high-risk serotypes of HPV are a risk factor.</p>
          </list-item>
          <list-item>
            <p><bold>Adenocarcinoma</bold>: This diagnosis is the invasive version of AIS, which can be found in the transition zone but is more commonly present within the cervical canal. This condition also derives from the glandular cells of the endometrium.<xref ref-type="bibr" rid="article-17035.r20">[20]</xref>&#x000a0;There has been an increase in this diagnosis even though there has been a reduction in cervical squamous carcinoma cases.
<list list-type="bullet"><list-item><p><bold>Adenocarcinoma malignum</bold>: A&#x000a0;rare cervical disease that is diagnosable with a pap smear. This disease usually arises in the endocervical region and is often misdiagnosed as a benign lesion.<xref ref-type="bibr" rid="article-17035.r21">[21]</xref>&#x000a0;Cytologic features include&#x000a0;significant cytoplasm with ovoid nuclei.<xref ref-type="bibr" rid="article-17035.r22">[22]</xref>&#x000a0;Histologically, the cells are in a honeycomb pattern.&#x000a0;The mucinous glands secrete copious fluid leading to symptomatic vaginal discharge.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Less commonly, abnormal Pap smears can arise from other histological subtypes. Cervical cancer can arise from a neuroendocrine origin, with the 2 main subtypes being large and small cell. Other types of tumors that can cause cervical cancer include sarcoma, lymphoma, and melanoma.</p>
      </sec>
      <sec id="article-17035.s5" sec-type="Clinical Pathology">
        <title>Clinical Pathology</title>
        <p>Abnormal Pap smears can present without any symptoms; it is important to ask about bleeding between periods, changes in the menstrual cycle, abnormal vaginal discharge, and dyspareunia. An increase in either unexplained bleeding or menstrual bleeding should raise concerns to evaluate the possibility of cervical cancer. Bleeding in postmenopausal women is especially concerning for neoplasms. If the patient has a more advanced case of cervical cancer, she can experience pelvic pain and dysuria.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-17035.s6" sec-type="Biochemical and Genetic Pathology">
        <title>Biochemical and Genetic Pathology</title>
        <p>The most common etiology of abnormal pap smears is due to HPV infections. HPV is an enveloped, circular, double-stranded deoxyribonucleic acid virus. The high-risk HPV serotypes are&#x000a0;16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 because they make the oncoproteins E6 and E7.<xref ref-type="bibr" rid="article-17035.r23">[23]</xref><xref ref-type="bibr" rid="article-17035.r24">[24]</xref>&#x000a0;Both of these oncoproteins result in the immortalization of the infected cervical cells. E6 binds to the intracellular transformation-related protein (p)53, causing it to degrade. The p53 protein is primarily utilized in the apoptotic pathway to upregulate the transcription of&#x000a0;p53 upregulated modulator of apoptosis, PUMA, and phorbol-12-myristate-13-acetate-induced protein 1, NOXA, leading to cell death. E7 focuses on activating the cell cycle, allowing for replication.</p>
        <p>In non-infected cells, one of the ways the cell cycle becomes arrested in G1 is with the binding of Rb to E2F. E2F is a transcriptional activator needed to progress the cell into the S phase but cannot when bound to Rb. In the high-risk strains of HPV, E7 binds to Rb, causing E2F to be released.<xref ref-type="bibr" rid="article-17035.r25">[25]</xref>&#x000a0;With E2F unbound from Rb, the infected cells are signaled to begin the S phase. Genetically, <italic toggle="yes">BRCA</italic> mutations play a role in the susceptibility of developing cervical cancer. <italic toggle="yes">BRCA</italic> stands for the breast cancer gene, and its translational product is a tumor suppressor protein. <italic toggle="yes">BRCA1 and 2</italic> are integral in many pathways but are especially important for deoxyribonucleic acid (DNA) repair. When there are double-stranded DNA breaks, these proteins help with homologous recombination repair. Without these proteins, there is genomic instability that can lead to neoplastic changes.<xref ref-type="bibr" rid="article-17035.r26">[26]</xref></p>
      </sec>
      <sec id="article-17035.s7" sec-type="Morphology">
        <title>Morphology</title>
        <p>The morphological changes recognized in abnormal Pap smears include multinucleation, hyperchromasia, and perinuclear cytoplasmic vacuolization. The nuclei of the cells can also become enlarged around three times greater than the normal cell nucleus. Other nucleic features include higher levels of keratinization but an absence of nucleoli.&#x000a0;These changes that squamous cells undergo are categorized as koilocytosis.</p>
      </sec>
      <sec id="article-17035.s8" sec-type="Mechanisms">
        <title>Mechanisms</title>
        <p>A Pap smear is collected with a brush inserted into the cervical os. It is important to have the brush extend beyond the visualized portion to increase the chance of successfully collecting cells from the transition zone. A similar tool to the brush is a spatula or broom. The 2 mechanisms for analyzing the collected cells are liquid-based cytology (thin prep, sure path) and conventional cytology. There are 2 subtypes of this cytology.<xref ref-type="bibr" rid="article-17035.r27">[27]</xref>&#x000a0;One allows for the collection device to be broken off and kept with the sample that is to be analyzed.&#x000a0;Another requires the aggravation of the collection tool since the tool does not go with the sample to be analyzed.</p>
        <p>Liquid-based cytology preserves the cells in a buffered alcoholic solution. It has been suggested that liquid-based can better identify glandular pathology. The conventional cytology method directly transfers the cells collected from the brush onto a slide. This transfer is why this technique is called a pap smear. When transferring the specimen onto the slide, it is important to minimize drying artifacts due to prolonged contact with the air. According to the American College of Obstetricians and Gynecologists (ACOG), both the liquid-based and conventional techniques are equally effective at screening for cervical cancer.</p>
      </sec>
      <sec id="article-17035.s9" sec-type="Clinicopathologic Correlations">
        <title>Clinicopathologic Correlations</title>
        <p>Abnormal pap smear findings for ACG in the setting of patients with HPV serotype 16/18 are at increased risk for AIS and should have more careful screening. When there&#x000a0;is AIS with concomitant LSIL, the physician should progress the workup as if it is an AIS diagnosis.</p>
      </sec>
      <sec id="article-17035.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The Papanicolaou smear is an effective screening test that detects cervical cancer as well as cellular changes that have the potential to develop into cervical cancer. Any diagnosis of an atypical pap smear results in more frequent and/or further testing. Below are the current recommendations from ACOG for each abnormal result.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Atypical squamous cells of undetermined significance</bold>, ASC-US: This management plan depends on the age of the patient. For patients between 21&#x000a0;and 24, repeat Pap smear in 1 year if the status of the HPV is positive or unknown. It is also acceptable to perform a reflex HPV test on the same pap smear sample. HPV status will determine future pap smear frequencies. If HPV is negative, then the patient is recommended for follow-up in 3 years. If the follow-up Pap smear continues to show ASC-US, then an additional Pap smear in 1 year is recommended. For patients between 25&#x000a0;and 29, screening is still the same if they have negative HPV. However, if they have positive HPV, colposcopy is recommended instead of waiting one year for a follow-up pap smear. If at the follow-up pap smear, ASC-US is still present, the next step is colposcopy. For patients between 30 to 65 years of age, there is a more significant concern for the progression of cervical cancer. If ASC-US is documented on a pap smear and they are HPV negative, they will follow the same process as the other age groups. If HPV status is positive or unknown, then a repeat pap smear is recommended within four months.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>LSIL</bold>: Repeat Pap smear in 1 year.</p>
          </list-item>
          <list-item>
            <p><bold>Atypical squamous cells</bold>, ASC-H: Further test the patient immediately with colposcopy.</p>
          </list-item>
          <list-item>
            <p><bold>HSIL</bold>: Further test the patient immediately with colposcopy.</p>
          </list-item>
          <list-item>
            <p><bold>AGC</bold>: Further testing can include endocervical sampling and an endometrial biopsy to source the location of the cells. It is essential to ask for pointed family history at this time. The patient should have her HPV status evaluated.</p>
          </list-item>
          <list-item>
            <p><bold>AIS</bold>: Immediate diagnostic excision procedure along with an endocervical and endometrial biopsy. The diagnostic excision will help confirm diagnosis as well as understand the extent of the invasion.</p>
          </list-item>
          <list-item>
            <p><bold>Squamous cell carcinoma</bold>: Immediate excision and further workup are necessary.</p>
          </list-item>
        </list>
        <p>Guidelines for recommendations can vary when looking at different societies and groups.</p>
      </sec>
      <sec id="article-17035.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17035&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17035">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17035/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17035">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17035.s12">
        <fig id="article-17035.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Squamous Cells with Acute Inflammation. The image shows a microscopic examination of squamous cells with acute inflammation, captured at &#x000d7;40 magnification and stained using the Papanicolaou stain. Contributed by F Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pmn__squamo02" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17035.s13">
        <title>References</title>
        <ref id="article-17035.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nayar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wilbur</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>The Pap test and Bethesda 2014.</article-title>
            <source>Cancer Cytopathol</source>
            <year>2015</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>271</fpage>
            <page-range>271-81</page-range>
            <pub-id pub-id-type="pmid">25931431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Henson</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Herbst</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Noller</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop.</article-title>
            <source>JAMA</source>
            <year>1994</year>
            <month>Jun</month>
            <day>15</day>
            <volume>271</volume>
            <issue>23</issue>
            <fpage>1866</fpage>
            <page-range>1866-9</page-range>
            <pub-id pub-id-type="pmid">8196145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siegel</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Jemal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cancer statistics, 2019.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-34</page-range>
            <pub-id pub-id-type="pmid">30620402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000f8;rbye</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Suhrke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rev&#x000e5;</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Berland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maurseth</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Al-Shibli</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway.</article-title>
            <source>BMC Clin Pathol</source>
            <year>2017</year>
            <volume>17</volume>
            <fpage>18</fpage>
            <pub-id pub-id-type="pmid">28860942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koonmee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bychkov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shuangshoti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhummichitra</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Himakhun</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Karalak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rangdaeng</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>False-Negative Rate of Papanicolaou Testing: A National Survey from the Thai Society of Cytology.</article-title>
            <source>Acta Cytol</source>
            <year>2017</year>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>434</fpage>
            <page-range>434-440</page-range>
            <pub-id pub-id-type="pmid">28738387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castillo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Astudillo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Clavero</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Velasco</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ib&#x000e1;&#x000f1;ez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Sanjos&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>8</issue>
            <fpage>e0161403</fpage>
            <pub-id pub-id-type="pmid">27547971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wentzensen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arbyn</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>HPV-based cervical cancer screening- facts, fiction, and misperceptions.</article-title>
            <source>Prev Med</source>
            <year>2017</year>
            <month>May</month>
            <volume>98</volume>
            <fpage>33</fpage>
            <page-range>33-35</page-range>
            <pub-id pub-id-type="pmid">28279260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chatzistamatiou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moysiadis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vryzas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chatzaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kaufmann</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Soutschek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boecher</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tsertanidou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maglaveras</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jansen-Duerr</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Agorastos</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Cigarette Smoking Promotes Infection of Cervical Cells by High-Risk Human Papillomaviruses, but not Subsequent E7 Oncoprotein Expression.</article-title>
            <source>Int J Mol Sci</source>
            <year>2018</year>
            <month>Jan</month>
            <day>31</day>
            <volume>19</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29385075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roura</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Travier</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Waterboer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>de Sanjos&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>FX</given-names>
              </name>
              <name>
                <surname>Pawlita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pala</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Weiderpass</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Margall</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dillner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gram</surname>
                <given-names>IT</given-names>
              </name>
              <name>
                <surname>Tj&#x000f8;nneland</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Munk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Palli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Khaw</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Overvad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Clavel-Chapelon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mesrine</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fournier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fortner</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Ose</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Steffen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trichopoulou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lagiou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Orfanos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Masala</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tumino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sacerdote</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Polidoro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mattiello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Bueno-de-Mesquita</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Quir&#x000f3;s</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barricarte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Larra&#x000f1;aga</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ekstr&#x000f6;m</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lindquist</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Idahl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Travis</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Merritt</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gunter</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tommasino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Franceschi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Riboli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Castellsagu&#x000e9;</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>e0147029</fpage>
            <pub-id pub-id-type="pmid">26808155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marks</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gravitt</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Liaw</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tadesse</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Phongnarisorn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wootipoom</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Yuenyao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vipupinyo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rugpao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sriplienchan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Celentano</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>The association of hormonal contraceptive use and HPV prevalence.</article-title>
            <source>Int J Cancer</source>
            <year>2011</year>
            <month>Jun</month>
            <day>15</day>
            <volume>128</volume>
            <issue>12</issue>
            <fpage>2962</fpage>
            <page-range>2962-70</page-range>
            <pub-id pub-id-type="pmid">20734390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conlon</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Diethylstilbestrol: Potential health risks for women exposed in utero and their offspring.</article-title>
            <source>JAAPA</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>49</fpage>
            <page-range>49-52</page-range>
            <pub-id pub-id-type="pmid">28098674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garrett</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>McCann</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Abnormal cytology in 2012: management of atypical squamous cells, low-grade intraepithelial neoplasia, and high-grade intraepithelial neoplasia.</article-title>
            <source>Clin Obstet Gynecol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-34</page-range>
            <pub-id pub-id-type="pmid">23337842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ciavattini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Clemente</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsiroglou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sopracordevole</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Serri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Delli Carpini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papiccio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cattani</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be?</article-title>
            <source>Arch Gynecol Obstet</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>295</volume>
            <issue>4</issue>
            <fpage>997</fpage>
            <page-range>997-1003</page-range>
            <pub-id pub-id-type="pmid">28255767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r14">
          <label>14</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Khieu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <chapter-title>High-Grade Squamous Intraepithelial Lesion of the Cervix</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>11</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">28613479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katki</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Schiffman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Castle</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Fetterman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Poitras</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Lorey</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Raine-Bennett</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gage</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kinney</surname>
                <given-names>WK</given-names>
              </name>
            </person-group>
            <article-title>Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.</article-title>
            <source>J Low Genit Tract Dis</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>5 Suppl 1</issue>
            <fpage>S28</fpage>
            <page-range>S28-35</page-range>
            <pub-id pub-id-type="pmid">23519302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boyraz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Basaran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Salman</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ibrahimov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Onder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ozgul</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yuce</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Histological Follow-Up in Patients with Atypical Glandular Cells on Pap Smears.</article-title>
            <source>J Cytol</source>
            <year>2017</year>
            <season>Oct-Dec</season>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>203</fpage>
            <page-range>203-207</page-range>
            <pub-id pub-id-type="pmid">29118475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geier</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Creasman</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Clinical evaluation of atypical glandular cells of undetermined significance.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>184</volume>
            <issue>2</issue>
            <fpage>64</fpage>
            <page-range>64-9</page-range>
            <pub-id pub-id-type="pmid">11174481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barr</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Raza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cobb</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Clinical significance of atypical glandular cells in conventional pap smears in a large, high-risk U.S. west coast minority population.</article-title>
            <source>Acta Cytol</source>
            <year>2009</year>
            <season>Mar-Apr</season>
            <volume>53</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-9</page-range>
            <pub-id pub-id-type="pmid">19365967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hildesheim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lacey</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Devesa</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.</article-title>
            <source>Cancer</source>
            <year>2004</year>
            <month>Mar</month>
            <day>01</day>
            <volume>100</volume>
            <issue>5</issue>
            <fpage>1035</fpage>
            <page-range>1035-44</page-range>
            <pub-id pub-id-type="pmid">14983500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeuchi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Biology and treatment of cervical adenocarcinoma.</article-title>
            <source>Chin J Cancer Res</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>254</fpage>
            <page-range>254-62</page-range>
            <pub-id pub-id-type="pmid">27198186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ki</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Byun</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Hur</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>Adenoma malignum of the uterine cervix: report of four cases.</article-title>
            <source>World J Surg Oncol</source>
            <year>2013</year>
            <month>Jul</month>
            <day>26</day>
            <volume>11</volume>
            <fpage>168</fpage>
            <pub-id pub-id-type="pmid">23885647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>JX</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>ZQ</given-names>
              </name>
            </person-group>
            <article-title>[Clinical analysis of minimal deviation adenocarcinoma of the cervix: a report of five cases].</article-title>
            <source>Ai Zheng</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>12</issue>
            <fpage>1310</fpage>
            <page-range>1310-4</page-range>
            <pub-id pub-id-type="pmid">19080000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balasubramaniam</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Balakrishnan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Oon</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Key Molecular Events in Cervical Cancer Development.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2019</year>
            <month>Jul</month>
            <day>17</day>
            <volume>55</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">31319555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yao</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>QF</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.</article-title>
            <source>J Zhejiang Univ Sci B</source>
            <string-date>2017 Mar.</string-date>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>256</fpage>
            <page-range>256-262</page-range>
            <pub-id pub-id-type="pmid">28271661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dick</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Molecular mechanisms underlying RB protein function.</article-title>
            <source>Nat Rev Mol Cell Biol</source>
            <year>2013</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>297</fpage>
            <page-range>297-306</page-range>
            <pub-id pub-id-type="pmid">23594950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mylavarapu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.</article-title>
            <source>Front Oncol</source>
            <year>2018</year>
            <volume>8</volume>
            <fpage>16</fpage>
            <pub-id pub-id-type="pmid">29459887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17035.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gibb</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Martens</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>The impact of liquid-based cytology in decreasing the incidence of cervical cancer.</article-title>
            <source>Rev Obstet Gynecol</source>
            <year>2011</year>
            <volume>4</volume>
            <issue>Suppl 1</issue>
            <fpage>S2</fpage>
            <page-range>S2-S11</page-range>
            <pub-id pub-id-type="pmid">21617785</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
